Thermo Fisher Scientific and AstraZeneca Partner on NGS-based Companion Diagnostics Development
Thermo Fisher Scientific and AstraZeneca will co-develop next-generation sequencing (NGS)-based companion diagnostics (CDx).
Read MorePosted by Chris Wolski | Sep 1, 2021 | Company News, Diagnostic Technologies |
Thermo Fisher Scientific and AstraZeneca will co-develop next-generation sequencing (NGS)-based companion diagnostics (CDx).
Read MorePosted by Chris Wolski | Aug 30, 2021 | Diabetes & Metabolic Diseases |
Testing for, monitoring, and controlling diabetes continues to become more robust, cost-effective, and nuanced.
Read MorePosted by Chris Wolski | Aug 25, 2021 | Molecular Diagnostics |
BD has launched a new, fully automated high-throughput diagnostic system automating infectious disease molecular testing.
Read MorePosted by Chris Wolski | Aug 24, 2021 | Uncategorized |
Researchers at SANKEN, Osaka University have demonstrated a method of releasing DNA at the point of measurement.
Read MorePosted by Chris Wolski | Aug 24, 2021 | Unknown Origin & Other Cancer Types |
Siemens Healthineers’ Enhanced Liver Fibrosis (ELF) Test was granted marketing authorization under the De Novo review pathway.
Read More